In this webinar Dr. D. D. Clark introduces BRAVECTO® Quantum (fluralaner for extended-release injectable suspension). A new product for dogs that kills fleas and ticks for up to 12 months. The presentation covers the latest trends, product efficacy, and how this new solution helps close compliance gaps with canine patients
This session explores the evolving threat of ticks and fleas, highlighting new insights into vector-borne diseases that impact both pets and their families. Through a compelling case study and the latest research, we’ll examine the growing risks driven by travel and climate change. Attendees will gain practical strategies to engage clients in prevention and protect […]
This session will focus on Otitis Externa, a common yet often challenging condition in veterinary medicine.This talk will delve into the prevalence, clinical signs, underlying causes, and treatment challenges associated with this condition. Additionally, we will highlight Merck Animal Health’s innovative range of products designed for the management of otitis externa.
Save big on HomeAgain scanners! All display Tempscan microchip temperature readings
Nobivac® NXT Canine Flu H3N2 is a non-adjuvanted, freeze-dried injectable canine influenza virus H3N2 vaccine, utilizing RNA particle technology. The vaccine stimulates expression of the desired antigen to induce a protective immune response against canine influenza virus H3N2.
Abstract Background: An extended duration flea and tick medication of the isoxazoline class (fluralaner) was introduced in 2014 in the United States and other countries. A survey was developed in 2016 to gauge dog owner adherence with veterinary recommendations around the administration of preventive flea and tick medications. Current fluralaner-using dog owners were also asked […]
Abstract Background: Fluralaner is the first orally administered isoxazoline to provide 12 weeks of activity against fleas and ticks after a single administration. As a result of its potent anti-flea activity, oral fluralaner may be proposed as a component of a strategy for the control of flea allergy dermatitis (FAD) in dogs. The open field […]